Another supporting finding is that FCGBP in thyroid cancer can functionally synergize with TFF3 through genetic co-expression, and thus contributing to poor survival in thyroid cancer patients with low TFF3 level [48]. The gene discussed is TFF3; the disease is thyroid gland carcinoma.